BDNF and schizophrenia: Recently it is suggested that antidepressant and antipsychotic treatments ameliorates disturbed monoamine systems caused by reduced BDNF activity, while reduced BDNF levels lead to differential treatment response in schizophrenia patients caused by stress and lack of neuronal activity [5].